W

Westlake Omics 西湖欧米

16 employees

Westlake Omics focuses on applying mass spectrometry-based proteomics and other Omics technologies to address pressing clinical needs.

Basic info

biotechnology research

Biotechnology

Artificial Intelligence

药物研发

AI

蛋白质组学

精准医学

人工智能

Medical

Health Care

大数据

2020

W

Westlake Omics 西湖欧米 raised undisclosed on January 13, 2022

Investors: Med-Fine Capital and Hillhouse Capital Management